Nosocomial Pneumonia

This multi-contributed text, co-ordinated by one of the leading authorities in the field, is a unique resource to cover in depth the management of the important issue of Nosocomial Pneumonia in respiratory medicine and critical care. This disease presents the clinician with a variety of challenges, in both diagnosis and management, all of which represent a significant concern for the welfare of patients whose ability to combat infection is frequently already compromised. Nosocomial Pneumonia: Strategies for Management is dedicated specifically to this most common hospital acquired respiratory infection and reviews important new advances in therapeutics, including drug resistance. It is an essential resource for all postgraduates and specialist physicians in pulmonology and infectious diseases.

This multi-contributed text, co-ordinated by one of the leadingauthorities in the field, is a unique resource to cover in depththe management of the important issue of Nosocomial Pneumonia inrespiratory medicine and critical care. This disease presents theclinician with a variety of challenges, in both diagnosis andmanagement, all of which represent a significant concern for thewelfare of patients whose ability to combat infection is frequentlyalready compromised.Nosocomial Pneumonia: Strategies for Management isdedicated specifically to this most common hospital acquiredrespiratory infection and reviews important new advances intherapeutics, including drug resistance. It is an essentialresource for all postgraduates and specialist physicians inpulmonology and infectious diseases.

Preface.List of Contributors.Abbreviations.1. Health Care Associated-Pneumonia: Epidemiology, Microbiologyand Clinical Outcomes (Dr. Marcos I. Restrepo and Dr. AntonioAnzuelo, San Antonio, Texas. US).2. Prevention of Hospital-Acquired Pneumonia (Dr. Rafael Sierraand Antonio Gordillo, Cádiz, Spain).3. Role of the microbiology laboratory in the diagnosis ofventilator-associated pneumonia (Dr. Emilio Bouza, Dra.Almudena Burillo, Dra. Patricia Muñoz, MadridSpain).4. Pathophysiology of Pneumonia (Dra Amalia Alcón, Dr.Mauricio Valencia, Dr. Antoni Torres, Barcelona, Spain).5. Clinical approach to the patient with HAP (Dr. Jordi RelloTarragona, Spain & Dr. Miguel Gallego, Sabadell, Spain).6. Pneumonia due to Pseudomonas aeruginosa (Dr. JordiVallés and Dra. Dolors Marisca, Sabadell. Spain).7. Hospital acquired-pneumonia caused by Staphylococcus aureus(Dra. Despoina Koulenti, Athens, Greece; Dr. Kemal AgbahtAnkara, Turkey).8. Nosocomial pneumonia by Acinetobacter baumannii (Dr.José Garnacho-Montero and Da. Eugenia Pachón, Dr.J.M. Cisneros, Sevilla, Spain).9. Fungal pneumonia (Dr. George Dimopoulos, Dr. E.Papadomichelakis, Dr. P. Kopteridis, Athens, Greece).10. General pharmacologic considerations and dose adjustment inantibiotic therapy for HAP (Dr. Pierluigi Viale and Dr. FedericoPea, Udine, Italy).11. Minimally Invasive Diagnostic Strategy in ImmunocompromizedPatients with Pulmonary Infiltrates (Dra. Sandra. De Miranda andDra. Élie Azoulay, Paris, France).12. Pneumonia in trauma patients (Dra. Helene A. Haeberle andDr. Wolfgang A. Krueger, Tubingen. Germany).13. Acute Respiratory Distress Syndrome and pneumonia (Dr. JeanChastre, Dr. Charles-Edouard Luyt, Dr. Jean LouisTrouillet, Dr. Alain Combes, Paris, France).14. Assessment of patients with poor resolution of HospitalAcquired Pneumonia (Dr. Richard G. Wunderink, Dr. Keenan A.Hawkins, Chicago, USA).15. Approach to Patients with recurrent VAP (Dr. Grant W.Waterer, Perth, Australia; Dr. Diego López. Madrid.Spain).16. Costs for Hospital-Acquired Pneumonia &Ventilator-Associated Pneumonia (Dr. Andrew F. Shorr and Dr.William L. Jackson, Washington, USA).Index.